Wholesale of pharmaceutical and medical goods
STIM AS
Revenue 2024
NOK 1.7bn
Operating profit
NOK 119.3m
Equity
NOK 243.9m
Incorporated
1992
Employees
64
Share capital
NOK 82,000
Varemerker (10)
| Name | Application no. | Reg. no. | Status | Status date | Expires |
|---|---|---|---|---|---|
| SUPERSMOLT | 200301084 | 227803 | Registrering opphørt | 2025-08-22 | 2025-08-22 |
| SUPERSMOLT | 200301084A | 225473 | Registrering opphørt | 2025-04-11 | 2025-04-11 |
| SUPERSMOLT | 200301409A | 225488 | Registrering opphørt | 2025-04-11 | 2025-04-11 |
| SmoltBooster | 201312383 | 274106 | Registrering opphørt | 2023-10-14 | 2023-10-14 |
| ReproBoost For Efficient Induction of Reproduction In Finfish | 201300596 | 270370 | Registrering opphørt | 2023-01-14 | 2023-01-14 |
| Europharma med helse som fag | 201204866 | 267001 | Registrering opphørt | 2022-05-09 | 2022-05-09 |
| STIM | 201816214 | 305003 | Registrert | 2019-07-31 | 2028-12-04 |
| STIM | 201901862 | 305004 | Registrert | 2019-07-31 | 2029-02-07 |
| Premium Superior | 201709369 | – | Endelig henlagt | 2018-02-22 | – |
| europharma | 200909117 | 253435 | Registrert | 2009-11-09 | 2029-11-09 |
Source: Patentstyret
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.